Member Info for LovableLumax

The CEO has 1,191,666 shares so I really hope he has bought some 10m shares as at 1.25p his holding is worth less than £30k which is poor.

Potential here is huge but that’s been said for years and working with Disney a few years ago I thought would be watershed but I think the CEO has to be replaced.

Also, I’m now concerned that a £2.6m unweighted pipeline is actually poor. Why so low and that’s not under negotiation merely what they’re actively targeting. Answers needed

2phevs don’t give me that. You were taking the pish and trying to talk me down as you didn’t want to hear my concerns about cash burn and the auditors signing off accounts H1

Anyway, one last thing. Can anyone see how many Berringee bought? He only has around 1m shares so no skin in the game and given he’s taken millions out of here surely he’s good for at least £100k? He bought feck all in the last raise at 3p so hope at 1.25p he’s filled his boots.

before heading off i’ll say fair play to lotm for having contrition. 2phevs the reason i don’t respect you if you pumping hard last year before selling out. fair enough bought back in and constantly continue to pump without doing regulatory research. i merely pointed out a few weeks ago a raise likely so waiting to buy and you decided to discredit me and poke fun at avacta and here you are without contrition. not only that still pumping without knowing an unweighted pipeline means nada.

enough from me for now but i’ll keep my eyes peeled and call bull**** when i read it.

I haven’t got it in for you but find your misleading statements dangerous for those who are naive and lap up your hyperbole.

I corrected you. You implied they had £2.6m booked which would have been positive but they merely have an unweighted pipline which means that’s what they’re actively targeting. If you don’t know the meaning of something look it up.

Good luck to all holders. It’s oversubscribed and I would hope the greedy CEO has bought at least £100k

2phevs still talking rubbish - £2.6 MILL booked up to March 31st is not far off double what this company has ever done in a whole year and H1 is the quietest revenue period..

No it’s an unweighted pipeline so means feck all and they likely had similar this time last year and the year before.

Guys I have to be honest I get the impression some of you only do research on LinkedIn. Have you not read past RNSs? Also, I again 2Phevs talking nonsense. He’s consistent. If you don’t understand what an unweighted pipeline is why wouldn’t you look it up? It’s far from booked revenue and isn’t even campaigns under negotiation just a pipeline of stuff they’re actively targeting (could be meetings booked, ITTs etc).

The only reason it wasn’t lower is due to the buying due to hype recently so the chunky sells absorbed. The CEO has been taking over 1/3rd of the money generated via his packages alone. For a loss making AiM stock creating no shareholder value it’s a crime.

The good thing is it’s cheap so will be oversubscribed and they’ll release some good news but it’ll fall again next year when they need another cash call.

They are hoping to break even next year. In 2022 they had admin expenses of £16.83m FFS. All you have to do is think the CEO and CFO will likely eat up nearly 20% of the raise in their packages in one year.

Look through the last raise doc. Same stuff regurgitated.

LOTM you don’t need to apologise. People should do their research and when there were less positive news you listened and didn’t shout it down and try and discredit. Hopefully short term pain before gain.

in the last 2 years (and before) the ceo and cfo have had packages worth well over 50% of the total revenue. what a joke. i mean how is berringer commanding a basic of nearly £500k and why the **** are they getting bonuses on top!?

2021 packages versus revenue - ceo £678,000, cfo £345,000 so £1.23m they take from £2m revenue so nearly 62%.

2022 - ceo £574,000, cfo £357,000, £931,000 of £1.5m revenue £1.5m so just over 62%.

what a joke.

Sound, fair enough but this isn’t one that came out of the blue so selling over weeks looks fishy. As I say a raise inevitable. The selling could have been shorts but I doubt it. Some IIs have also been reducing (not rathbones as that’s nominees).

Anyway, short term pain and might be long term gain. Need a new CEO/CFO.

They certainly need to look closely at the identity of the seller over the last couple of weeks.

I’m sorry the above shows a complete lack of understanding. Whoever sold looked at their accounts and knew a raise in H1 inevitable so they rightly reduced their stake. That’s why I said it’s crazy to buy even with stupid LinkedIn posts as a raise en route.

CEO has no credibility. The raise will be oversubscribed given the price but there has been someone dumping for weeks. I do feel sorry for any newbies buying as a result of the incessant ramping here. Anyway, may well come good but always do your own research and read past RNSs. A lot of regurgitation today.

As I said I’m not gloating but pointing out it’s not healthy when a BB becomes too rampy and an echo chamber. As you know I’ve been invested for years and when I post a view which is balanced other holders should listen and not have the resident ramper throwing a hissy fit and trying to discredit.

I hope it comes good and maybe the BoD will buy lots of shares and not just a token number.

This is what you gave me stick for writing a few weeks ago -

I’m sure most know money is needed here before end of H1 (for auditors to sign off on accounts without ‘going concern’). I hold here and will buy more once funding clear. If they raise at a premium I’ll have to pay more but given the dire conditions and how hard raises are it might not happen. Potential here clearly massive but the market unforgiving and it’s been said potential massive for years.

Today MIRI wrote -

Shareholders should be aware that if the Fundraising does not complete by 30 June 2024, the Company's annual report and accounts will not be signed off by the Company's auditors on a going concern basis.

Anyway, I’m not happy with the discount and doubling of shares but it was likely and some incessant posters need to take stock and realise others with a different view are being honest and certainly not short.

this was from the 3p raise 12 months ago -

1. the announcements made by amazon and nbcu that they were, or intended, to enter the in-content advertising market;

2. conversations that the company is having with a number of tier 1 content supply businesses in the us. the company is working with five of the top ten largest content supply companies in the us and in dialogue with another four;

anyway, a lot of the same material as 12 months ago and 12 months before that albeit they are now looking to break even next year. all the linkedin posts etc have been posted for years. i’ve been invested here for many years and have seen it all. i moaned years ago about stephan’s package being 50% of the year’s revenue and he has **** all shares. says it all. no skin in the game.

i did call this and recently got stung on avacta which 2phevs thought funny.

anyway, they’ll be over subscribed i suspect given the shocking price and now doubling number of shares. ceo a joke.

You must type like an experienced secretary as they're long winded to say the least. Bizarre you spend a lot of time posting on a company you just trade in as you do with sometimes 20 others. Each to their own

Wynd you said you have 10 to 20 stocks you trade to make a modest percentage on which makes sense. Given this is one of 10 to 20 how come you have posted 175 times on here in the last 30 days? Really prolific, is this your job now to save shareholders from themselves? Surprised you can find the time with up to 20 stocks to trade on

They're holding for nominees so retail and wouldn't be listed on avacta's website

Zak and others are saying the recent fall to 43p if where it needs to close above. Anyway, we'll see but yeah 2 weekly RNS soon and who knows where else other news could come from.

I agree BV. To be honest if they have not sorted funding out by the end of this year through deals or sale of DX it will be poor. 2 weekly should highlight even more efficacy data, more 3 weekly data to come as 4 patients with high fap continue to take drug and were showing reductions (albeit small but expected to reduce further) and they are working on more potent toxins which will be revealed in H2 which is not dissimilar to a for sale sign. Defo makes sense to go for the ACDs rather than 3996 and other older molecules.